Tag: Vaccines

Fifty-four percent of solid organ transplant recipients had antibody response after two doses of SARS-CoV-2 mRNA vaccine

CVST with thrombocytopenia reported after COVID-19 vaccine with adenoviral vector; management similar to heparin-induced thrombocytopenia

Officials hope requirement will be an incentive for these facilities to keep giving shots even as the pandemic wanes

Antibody response in IBD patients, including those receiving biologic therapy at the time of vaccination, similar to that of controls without IBD

Only 29 percent of parents of children younger than 18 years of age said they would get their child vaccinated 'right away'

Vaccine hesitancy may hamper efforts to achieve immunity in 70 to 85 percent of the total U.S. population

Second study shows lower neutralizing antibody titers against SARS-CoV-2 after the first dose among elderly patients with multiple myeloma

Accelerated decline in nonpharmaceutical intervention adherence could undermine vaccine-related gains

Real-world study shows vaccine effectiveness of 97.2 percent against COVID-19-related hospitalization, 96.7 percent against COVID-19-related death

Company also plans to apply to the FDA this month for full approval of the vaccine for use in people ages 16 to 85 years